David M. Knott Jr’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.6M Sell
1,002,900
-57,100
-5% -$482K 5.24% 4
2026
Q2
$8.4M Hold
1,060,000
– – 4.44% 4
2026
Q1
$6.15M Buy
1,060,000
+90,000
+9% +$597K 3.66% 6
2025
Q4
$7.61M Sell
970,000
-45,000
-4% -$354K 3.53% 5
2025
Q3
$8.26M Sell
1,015,000
-45,000
-4% -$299K 3.33% 6
2025
Q2
$4.95M Sell
1,060,000
-50,000
-5% -$229K 2.24% 7
2025
Q1
$6.09M Buy
1,110,000
+110,000
+11% +$444K 2.88% 7
2024
Q4
$3.39M Hold
1,000,000
– – 1.23% 15
2024
Q3
$2.85M Buy
1,000,000
+180,000
+22% +$462K 1% 22
2024
Q2
$1.84M Buy
820,000
+220,000
+37% +$443K 0.74% 29
2024
Q1
$1.33M Buy
600,000
+212,090
+55% +$549K 0.47% 37
2023
Q4
$912K Buy
+387,910
New +$716K 0.35% 34

Other funds holding XERS

David M. Knott Jr's XERS Position: Q3 2026 in Review

David M. Knott Jr reduced its Xeris Biopharma Holdings (XERS) stake by 5.4% in Q3 2026, selling an estimated $482K and leaving 1,002,900 shares worth $9.6M. The position accounts for 5.24% of the portfolio, ranked #4.

David M. Knott Jr first reported a position in XERS in Q4 2023 and has held it in 12 quarters since. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • David M. Knott Jr held 1,002,900 shares of Xeris Biopharma Holdings worth $9.6M as of Q3 2026.
  • David M. Knott Jr sold 57,100 Xeris Biopharma Holdings shares in Q3 2026, an estimated $482K.
  • Xeris Biopharma Holdings made up 5.24% of David M. Knott Jr's portfolio in Q3 2026, its #4 holding.
  • David M. Knott Jr first reported a position in Xeris Biopharma Holdings in Q4 2023 and has held it in 12 quarters since.
  • 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on David M. Knott Jr's 13F filing for Q3 2026, filed 12 Nov 2026.